Michigan State University researchers have developed TriMag, a biodegradable microrobot capable of combining magnetic navigation, real-time imaging, and localized tumor ablation in a single microscopic device. Led by Jinxing Li, professor at the MSU College of Engineering and the Institute for Quantitative Health Science and Engineering, the project involved collaborations with Henry Ford Health and Arizona State University. The findings were recently published in Advanced Materials. TriMag measures less than the width of a human hair and is engineered to operate precisely within complex biological environments. The device integrates three critical functions: external magnetic steering for targeted movement, magnetic particle imaging for real-time three-dimensional tracking without radiation interference, and magnetic hyperthermia to selectively heat and destroy cancer cells. By consolidating these capabilities into one unit, TriMag addresses previous limitations in microrobotics, where devices often struggled with accurate deep-tissue imaging, reliable localization, and multi-functional deployment. The microrobots feature a sperm-like morphology optimized for swimming through viscous biological fluids. Fabricated using high-precision three-dimensional printing, the structure combines edible polymers with microscopic iron oxide particles. Once their therapeutic or diagnostic tasks are completed, the robots safely biodegrade, with their iron components assimilated into natural bodily processes or eliminated through standard metabolic pathways. Preclinical trials in animal models and biological fluids demonstrate the platform's viability for multiple medical applications. In oncology, TriMag enables highly targeted hyperthermia treatments that eliminate tumors while preserving surrounding healthy tissue, potentially reducing systemic side effects and recovery times. Ophthalmology procedures could also be transformed, as clinicians may guide the microrobots to precise ocular locations, eliminating the need for direct needle injections. Neurosurgical interventions stand to benefit significantly as well, with the devices offering a minimally invasive method to navigate delicate brain structures, carry contrast agents for safer imaging, and perform complex procedures with smaller incisions. Despite the promising preclinical data, human clinical trials remain years away. The development of a multifunctional, biocompatible, and precisely controllable microrobot platform represents a substantial engineering milestone. By merging navigation, visualization, and therapeutic delivery into a hair-width device, researchers have established a robust foundation for next-generation medical robotics. If future trials replicate these results, TriMag could redefine precision medicine by delivering targeted interventions with minimal patient discomfort and faster clinical recovery.